A Study of Oral Contraception Under Simulated OTC Conditions
Status:
Terminated
Trial end date:
2018-11-14
Target enrollment:
Participant gender:
Summary
This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a
progestin only pill for contraception, in a manner consistent with the OTC package directions
in an Over-the-Counter (OTC)-like setting.